Nocturnal sleep structure and temperature slope in MPTP treated monkeys
- PMID: 10651108
- DOI: 10.1007/s007020050228
Nocturnal sleep structure and temperature slope in MPTP treated monkeys
Abstract
The nocturnal sleep of three 1-Methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) treated monkeys (one non-motor disabled and two severely motor disabled), while held in a primate chair was registered using a reversible system for head fixation and chronic recordings. Two electroencephalogram (EEG) channels, one electrooculogram (EOG) and one electromyogram (EMG) channel were monitored constantly and tape recorded during eight nights for posterior analyses. Subcutaneous temperature was registered each minute using a radio telemetry system. An analysis of sleep patterns and temperature parameters revealed lighter sleep, decreased amounts of slow wave and rapid eye movement (REM) sleep and lower temperature values in the two motor disabled MPTP-treated monkeys than in the non-motor disabled monkey. The temperature linear slope was negative in the case of one disabled monkey for just one night. Although the motor disability of the two monkeys was similar, their sleep organization patterns and temperatures slopes differed. The present study confirmed the differential vulnerability of the nigrostriatal system of monkeys to MPTP, suggesting that if a high cumulative dose was needed to reach stable motor alterations, the cumulative dose-effect of the toxin independent of the nigrostriatal system might be responsible for non-motor symptoms that also appear in Parkinson's disease besides the classic tetrad.
Similar articles
-
The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.Adv Neurol. 1993;60:119-22. Adv Neurol. 1993. PMID: 8093574 No abstract available.
-
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.Adv Neurol. 1993;60:113-8. Adv Neurol. 1993. PMID: 8093573 No abstract available.
-
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.Synapse. 1999 Jun 1;32(3):153-64. doi: 10.1002/(SICI)1098-2396(19990601)32:3<153::AID-SYN2>3.0.CO;2-X. Synapse. 1999. PMID: 10340626
-
Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a review.Acta Neurol Scand Suppl. 1991;136:29-36. doi: 10.1111/j.1600-0404.1991.tb05017.x. Acta Neurol Scand Suppl. 1991. PMID: 1801534 Review.
-
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
Cited by
-
Early onset of sleep/wake disturbances in a progressive macaque model of Parkinson's disease.Sci Rep. 2022 Oct 19;12(1):17499. doi: 10.1038/s41598-022-22381-z. Sci Rep. 2022. PMID: 36261689 Free PMC article.
-
Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.J Clin Sleep Med. 2016 Jun 15;12(6):895-903. doi: 10.5664/jcsm.5896. J Clin Sleep Med. 2016. PMID: 27070245 Free PMC article.
-
Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.J Neurosci. 2014 Jul 2;34(27):9124-33. doi: 10.1523/JNEUROSCI.0181-14.2014. J Neurosci. 2014. PMID: 24990932 Free PMC article.
-
Persistent short-term memory defects following sleep deprivation in a drosophila model of Parkinson disease.Sleep. 2009 Aug;32(8):984-92. doi: 10.1093/sleep/32.8.984. Sleep. 2009. PMID: 19725249 Free PMC article.
-
Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.Front Neuroanat. 2010 Nov 23;4:145. doi: 10.3389/fnana.2010.00145. eCollection 2010. Front Neuroanat. 2010. PMID: 21151379 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources